Similar articles

• [Cutaneous adverse effects of mesotherapy].

  Tennstedt D, Lachapelle JM. Tennstedt D, et al. Ann Dermatol Venereol. 1997;124(2):192-6. Ann Dermatol Venereol. 1997. PMID: 9740838 French. No abstract available.
• Postinjection corticosteroid atrophy.

  Roller MC. Roller MC. J Indiana State Med Assoc. 1979 Apr;72(4):268-9. J Indiana State Med Assoc. 1979. PMID: 438522 No abstract available.
• [Injection technics and immunization risks].

  Asboe-Hansen G. Asboe-Hansen G. Ugeskr Laeger. 1971 May 28;133(21):1036. Ugeskr Laeger. 1971. PMID: 5088318 Danish. No abstract available.
• Mesotherapy: a bibliographical review.

  Herreros FO, Moraes AM, Velho PE. Herreros FO, et al. An Bras Dermatol. 2011 Jan-Feb;86(1):96-101. doi: 10.1590/s0365-05962011000100013. An Bras Dermatol. 2011. PMID: 21437529 Review. English, Portuguese.
• Mesotherapy, definition, rationale and clinical role: a consensus report from the Italian Society of Mesotherapy.

  Mammucari M, Gatti A, Maggiori S, Bartoletti CA, Sabato AF. Mammucari M, et al. Eur Rev Med Pharmacol Sci. 2011 Jun;15(6):682-94. Eur Rev Med Pharmacol Sci. 2011. PMID: 21796873 Review.